- Home
- AI vs VCEL Comparison
AI vs VCEL Comparison
Compare AI & VCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AI
- VCEL
- Stock Information
- Founded
- AI 2009
- VCEL 1989
- Country
- AI United States
- VCEL United States
- Employees
- AI 1181
- VCEL N/A
- Industry
- AI Computer Software: Prepackaged Software
- VCEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AI Technology
- VCEL Health Care
- Exchange
- AI Nasdaq
- VCEL Nasdaq
- Market Cap
- AI 2.5B
- VCEL 2.1B
- IPO Year
- AI 2020
- VCEL 1997
- Fundamental
- Price
- AI $17.97
- VCEL $35.87
- Analyst Decision
- AI Hold
- VCEL Strong Buy
- Analyst Count
- AI 18
- VCEL 7
- Target Price
- AI $29.81
- VCEL $61.29
- AVG Volume (30 Days)
- AI 11.7M
- VCEL 614.9K
- Earning Date
- AI 09-03-2025
- VCEL 07-31-2025
- Dividend Yield
- AI N/A
- VCEL N/A
- EPS Growth
- AI N/A
- VCEL 2045.40
- EPS
- AI N/A
- VCEL 0.13
- Revenue
- AI $389,056,000.00
- VCEL $249,119,000.00
- Revenue This Year
- AI $23.14
- VCEL $23.03
- Revenue Next Year
- AI $19.19
- VCEL $24.51
- P/E Ratio
- AI N/A
- VCEL $284.01
- Revenue Growth
- AI 25.27
- VCEL 16.13
- 52 Week Low
- AI $14.70
- VCEL $33.09
- 52 Week High
- AI $45.08
- VCEL $63.00
- Technical
- Relative Strength Index (RSI)
- AI 30.06
- VCEL 46.58
- Support Level
- AI $14.70
- VCEL $35.24
- Resistance Level
- AI $18.64
- VCEL $38.08
- Average True Range (ATR)
- AI 1.14
- VCEL 1.80
- MACD
- AI -0.78
- VCEL 0.09
- Stochastic Oscillator
- AI 27.87
- VCEL 45.80
About AI C3.ai Inc.
C3.ai Inc is an enterprise artificial intelligence company. The company provides software-as-a-service applications that enable customers to rapidly develop, deploy, and operate large-scale Enterprise AI applications across any infrastructure. It provides solutions under three divisions namely, The C3 AI Platform, which is an end-to-end application development and runtime environment for designing, developing, and deploying AI applications: C3 AI Applications, which is a portfolio of pre-built, extensible, industry-specific, and application-specific Enterprise AI applications: and C3 Generative AI, which combines the utility of large language models. Geographically the company derives revenue from North America, Europe, the Middle East and Africa, Asia Pacific, and the Rest of the World.
About VCEL Vericel Corporation
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.